Cargando…
N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in patients with pre-capillary pulmonary hypertension (PH). As it accumulates in the presence of impaired renal function, the clinical utility of NT-proBNP in PH patients with concomitant renal insufficienc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994009/ https://www.ncbi.nlm.nih.gov/pubmed/24751887 http://dx.doi.org/10.1371/journal.pone.0094263 |
_version_ | 1782312649019621376 |
---|---|
author | Harbaum, Lars Hennigs, Jan K. Baumann, Hans J. Lüneburg, Nicole Griesch, Elisabeth Bokemeyer, Carsten Grünig, Ekkehard Klose, Hans |
author_facet | Harbaum, Lars Hennigs, Jan K. Baumann, Hans J. Lüneburg, Nicole Griesch, Elisabeth Bokemeyer, Carsten Grünig, Ekkehard Klose, Hans |
author_sort | Harbaum, Lars |
collection | PubMed |
description | N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in patients with pre-capillary pulmonary hypertension (PH). As it accumulates in the presence of impaired renal function, the clinical utility of NT-proBNP in PH patients with concomitant renal insufficiency remains unclear. In a retrospective approach, patients with pre-capillary PH (group I or IV) and concomitant renal insufficiency at time of right heart catheterization (glomerular filtration rate (GFR) ≤60 ml/min/1.73 m(2)) were identified out of all prevalent pre-capillary PH patients treated at a single center. Forty patients with renal insufficiency (25.8%) were identified and matched regarding hemodynamic parameters with a control group of 56 PH patients with normal renal function (GFR >60 ml/min/1.73 m(2)). Correlations of NT-proBNP levels with hemodynamic and prognostic parameters (time to clinical worsening and overall survival) were assessed. Overall, GFR correlated inversely with NT-proBNP and had the strongest influence on NT-proBNP levels in a stepwise multiple linear regression model including hemodynamic parameters and age (r(2) = 0.167). PH patients with renal insufficiency had significant higher levels of NT-proBNP (median: 1935 ng/l vs. 573 ng/l, p = 0.001). Nevertheless, NT-proBNP correlated with invasive hemodynamic parameters in these patients. Using higher cut-off values than in patients with preserved renal function, NT-proBNP levels were significantly associated with time to clinical worsening (>1660 ng/l, p = 0.001) and survival (>2212 ng/l, p = 0.047) in patients with renal insufficiency. Multivariate Cox’s proportional hazards analysis including established prognostic parameters, age and GFR confirmed NT-proBNP as an independent risk factor for clinical worsening in PH patients with renal insufficiency (hazard ratio 4.8, p = 0.007). Thus, in a retrospective analysis we showed that NT-proBNP levels correlated with hemodynamic parameters and outcome regardless of renal function. By using higher cut-off values, NT-proBNP seems to represent a valid clinical marker even in PH patients with renal insufficiency. |
format | Online Article Text |
id | pubmed-3994009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39940092014-04-25 N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency Harbaum, Lars Hennigs, Jan K. Baumann, Hans J. Lüneburg, Nicole Griesch, Elisabeth Bokemeyer, Carsten Grünig, Ekkehard Klose, Hans PLoS One Research Article N-terminal pro-brain natriuretic peptide (NT-proBNP) is a routinely used prognostic parameter in patients with pre-capillary pulmonary hypertension (PH). As it accumulates in the presence of impaired renal function, the clinical utility of NT-proBNP in PH patients with concomitant renal insufficiency remains unclear. In a retrospective approach, patients with pre-capillary PH (group I or IV) and concomitant renal insufficiency at time of right heart catheterization (glomerular filtration rate (GFR) ≤60 ml/min/1.73 m(2)) were identified out of all prevalent pre-capillary PH patients treated at a single center. Forty patients with renal insufficiency (25.8%) were identified and matched regarding hemodynamic parameters with a control group of 56 PH patients with normal renal function (GFR >60 ml/min/1.73 m(2)). Correlations of NT-proBNP levels with hemodynamic and prognostic parameters (time to clinical worsening and overall survival) were assessed. Overall, GFR correlated inversely with NT-proBNP and had the strongest influence on NT-proBNP levels in a stepwise multiple linear regression model including hemodynamic parameters and age (r(2) = 0.167). PH patients with renal insufficiency had significant higher levels of NT-proBNP (median: 1935 ng/l vs. 573 ng/l, p = 0.001). Nevertheless, NT-proBNP correlated with invasive hemodynamic parameters in these patients. Using higher cut-off values than in patients with preserved renal function, NT-proBNP levels were significantly associated with time to clinical worsening (>1660 ng/l, p = 0.001) and survival (>2212 ng/l, p = 0.047) in patients with renal insufficiency. Multivariate Cox’s proportional hazards analysis including established prognostic parameters, age and GFR confirmed NT-proBNP as an independent risk factor for clinical worsening in PH patients with renal insufficiency (hazard ratio 4.8, p = 0.007). Thus, in a retrospective analysis we showed that NT-proBNP levels correlated with hemodynamic parameters and outcome regardless of renal function. By using higher cut-off values, NT-proBNP seems to represent a valid clinical marker even in PH patients with renal insufficiency. Public Library of Science 2014-04-21 /pmc/articles/PMC3994009/ /pubmed/24751887 http://dx.doi.org/10.1371/journal.pone.0094263 Text en © 2014 Harbaum et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Harbaum, Lars Hennigs, Jan K. Baumann, Hans J. Lüneburg, Nicole Griesch, Elisabeth Bokemeyer, Carsten Grünig, Ekkehard Klose, Hans N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency |
title | N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency |
title_full | N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency |
title_fullStr | N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency |
title_full_unstemmed | N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency |
title_short | N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency |
title_sort | n-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994009/ https://www.ncbi.nlm.nih.gov/pubmed/24751887 http://dx.doi.org/10.1371/journal.pone.0094263 |
work_keys_str_mv | AT harbaumlars nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency AT hennigsjank nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency AT baumannhansj nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency AT luneburgnicole nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency AT grieschelisabeth nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency AT bokemeyercarsten nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency AT grunigekkehard nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency AT klosehans nterminalprobrainnatriureticpeptideisausefulprognosticmarkerinpatientswithprecapillarypulmonaryhypertensionandrenalinsufficiency |